Full View

A specific microRNA profile as predictive biomarker for systemic treatment in patients with metastatic colorectal cancer

D Poel, EC Gootjes, L Bakkerus, W Trypsteen… - Cancer …, 2020 - Wiley Online Library
Background Palliative systemic therapy is currently standard of care for patients with
extensive metastatic colorectal cancer (mCRC). A biomarker predicting chemotherapy …
被引用次数：11 相关文章

A specific microRNA profile as predictive biomarker for systemic treatment in patients with metastatic colorectal cancer

D Poel, EC Gootjes, L Bakkerus, W Trypsteen… - Cancer …, 2020 - search.proquest.com
Background Palliative systemic therapy is currently standard of care for patients with
extensive metastatic colorectal cancer (mCRC). A biomarker predicting chemotherapy …

A specific microRNA profile as predictive biomarker for systemic treatment in patients with metastatic colorectal cancer

D Poel, EC Gootjes, L Bakkerus… - Cancer …, 2020 - researchinformation.amsterdamumc …
Background: Palliative systemic therapy is currently standard of care for patients with
extensive metastatic colorectal cancer (mCRC). A biomarker predicting chemotherapy …
[PDF] ru.nl

[PDF][PDF] A specific microRNA profile as predictive biomarker for systemic treatment in patients with metastatic colorectal cancer

D Poel, EC Gootjes, L Bakkerus, W Trypsteen… - 2020 - repository.ubn.ru.nl
BACKGROUND: Palliative systemic therapy is currently standard of care for patients with
extensive metastatic colorectal cancer (mCRC). A biomarker predicting chemotherapy …

A specific microRNA profile as predictive biomarker for systemic treatment in patients with metastatic colorectal cancer.

D Poel, EC Gootjes, L Bakkerus, W Trypsteen… - Cancer …, 2020 - europepmc.org
Background Palliative systemic therapy is currently standard of care for patients with
extensive metastatic colorectal cancer (mCRC). A biomarker predicting chemotherapy …
[PDF] archive.org

[PDF][PDF] A specific microRNA profile as predictive biomarker for systemic treatment in patients with metastatic colorectal cancer

D Poel, EC Gootjes, L Bakkerus, W Trypsteen… - Cancer …, 2020 - scholar.archive.org
Background: Palliative systemic therapy is currently standard of care for patients with
extensive metastatic colorectal cancer (mCRC). A biomarker predicting chemotherapy …

A specific microRNA profile as predictive biomarker for systemic treatment in patients with metastatic colorectal cancer

D van der Poel, EC Gootjes, L Bakkerus… - Cancer …, 2020 - repub.eur.nl
Background: Palliative systemic therapy is currently standard of care for patients with
extensive metastatic colorectal cancer (mCRC). A biomarker predicting chemotherapy …
[PDF] eur.nl

[PDF][PDF] A specific microRNA profile as predictive biomarker for systemic treatment in patients with metastatic colorectal cancer

D Poel, EC Gootjes, L Bakkerus, W Trypsteen… - Cancer Medicine, 2020 - pure.eur.nl
Background: Palliative systemic therapy is currently standard of care for patients with
extensive metastatic colorectal cancer (mCRC). A biomarker predicting chemotherapy …

A specific microRNA profile as predictive biomarker for systemic treatment in patients with metastatic colorectal cancer

D Poel, EC Gootjes, L Bakkerus… - Cancer …, 2020 - pubmed.ncbi.nlm.nih.gov
Background Palliative systemic therapy is currently standard of care for patients with
extensive metastatic colorectal cancer (mCRC). A biomarker predicting chemotherapy …
[HTML] nih.gov

[HTML][HTML] A specific microRNA profile as predictive biomarker for systemic treatment in patients with metastatic colorectal cancer

D Poel, EC Gootjes, L Bakkerus, W Trypsteen… - Cancer …, 2020 - ncbi.nlm.nih.gov
Background Palliative systemic therapy is currently standard of care for patients with
extensive metastatic colorectal cancer (mCRC). A biomarker predicting chemotherapy …